Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ-Reference-Cited by-同舟云学术

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ

Published:2016-11-01 Issue:12 Volume:7 Page:1161-1166
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Pujala Brahmam¹,Agarwal Anil K.¹,Middya Sandip²,Banerjee Monali²,Surya Arjun²,Nayak Anjan K.¹,Gupta Ashu¹,Khare Sweta¹,Guguloth Rambabu¹,Randive Nitin A.¹,Shinde Bharat U.¹,Thakur Anamika¹,Patel Dhananjay I.¹,Raja Mohd.¹,Green Michael J.³,Alfaro Jennifer⁴,Avila Patricio⁴,Pérez de Arce Felipe⁴⁵,Almirez Ramona G.³,Kanno Stacy³,Bernales Sebastián³,Hung David T.³,Chakravarty Sarvajit³,McCullagh Emma³,Quinn Kevin P.³,Rai Roopa³,Pham Son M.³

Affiliation:

1. Integral BioSciences, Pvt. Ltd., C-64, Hosiery Complex Phase II Extension, Noida, Uttar Pradesh 201306, India

2. Curadev, Pvt. Ltd., B-87, Sector 83, Noida, Uttar Pradesh 201305, India

3. Medivation, Inc., 525 Market Street, 36th Floor, San Francisco, California 94105, United States

4. Fundación Ciencia y Vida, Avenida Zañartu 1482, Ñuñoa, Santiago 7780272, Chile

5. Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas, Universidad Andrés Bello, Santiago 8370146, Chile

Funder

Medivation, Inc.

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.6b00356

Reference19 articles.

1. Regulation of B-cell fate by antigen-receptor signals

2. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells

3. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies

4. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors

5. Ibrutinib: First Global Approval

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel 6-amino-1,3,5-triazine derivatives as potent BTK inhibitors: structure-activity relationship (SAR) analysis and preliminary mechanism investigation;Bioorganic Chemistry;2023-01

2. Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions;Journal of Medicinal Chemistry;2022-12-12

3. Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance;Journal of Medicinal Chemistry;2022-05-20

4. QSAR analysis on a large and diverse set of potent phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using MLR and ANN methods;Scientific Reports;2022-04-12

5. Recent development of BTK-based dual inhibitors in the treatment of cancers;European Journal of Medicinal Chemistry;2022-04